Ultragenyx Pharmaceutical Inc.
2020 Q1 - 2025 Q4 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 40,233 | 0.2% | 1,749,268 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 11,038 | 0.0% | 303,565 | 6/30/2025 |
| 2024 Q3 | 11/14/2024 | 5,442 | 0.0% | 97,960 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 26,071 | 0.1% | 634,327 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 32,105 | 0.1% | 687,619 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 34,382 | 0.2% | 718,978 | 12/31/2023 |
| 2023 Q3 | 11/17/2023 | 26,676 | 0.2% | 748,278 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 27,876 | 0.2% | 604,287 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 31,109 | 0.2% | 775,775 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 30,628 | 0.2% | 661,083 | 12/31/2022 |
| 2022 Q3 | 11/15/2022 | 9,147 | 0.1% | 220,880 | 9/30/2022 |
| 2021 Q4 | 2/14/2022 | 242 | 0.0% | 2,876 | 12/31/2021 |
| 2020 Q3 | 11/16/2020 | 978 | 0.0% | 11,898 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 2,097 | 0.0% | 26,806 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 434 | 0.0% | 9,777 | 3/31/2020 |